Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
This trial is active, not recruiting.
|Sponsor||University of Michigan Cancer Center|
|Start date||March 2009|
|End date||May 2011|
|Trial size||120 participants|
|Trial identifier||NCT00858585, HUM 22831, UMCC 2008.066|
This study will examine genes in three different tissues and look for similarities and differences between normal cells and cancer cells. The tissues to be studies come from blood, lymph node and cancer.
Single nucleotide polymorphisms
time frame: time-independent
Female participants at least 18 years old.
Inclusion Criteria: - Age at least 18 years of age - Able to read and sign the informed consent - Able to provide specimens: one blood draw for white blood cells, provide permission to use tissue already collected.
|Official title||Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study|
|Principal investigator||Catherine Van Poznak, MD|
|Description||Subjects will be given an informed consent to read and sign The medical chart will be reviewed for diagnosis and treatment history Blood (about 4 tablespoons) will be drawn at a clinically available time. The lymph node and breast tumor tissue in the University of Michigan pathology repository will be used for research purposes|
Call for more information